These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3342359)

  • 1. Influence of estrogen receptor status on dietary risk factors for breast cancer.
    Hislop TG; Kan L; Coldman AJ; Band PR; Brauer G
    CMAJ; 1988 Mar; 138(5):424-30. PubMed ID: 3342359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotenoids, vitamin A, and estrogen receptor status in breast cancer.
    Rock CL; Saxe GA; Ruffin MT; August DA; Schottenfeld D
    Nutr Cancer; 1996; 25(3):281-96. PubMed ID: 8771571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
    Noma C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2004 Jul; 210(2):197-203. PubMed ID: 15183535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status.
    McCann SE; Kulkarni S; Trevisan M; Vito D; Nie J; Edge SB; Muti P; Freudenheim JL
    Breast Cancer Res Treat; 2006 Oct; 99(3):309-11. PubMed ID: 16541305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
    Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study.
    Deandrea S; Talamini R; Foschi R; Montella M; Dal Maso L; Falcini F; La Vecchia C; Franceschi S; Negri E
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2025-8. PubMed ID: 18708394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
    Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS
    Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer.
    Touillaud MS; Pillow PC; Jakovljevic J; Bondy ML; Singletary SE; Li D; Chang S
    Nutr Cancer; 2005; 51(2):162-9. PubMed ID: 15860438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptors and the pattern of relapse in breast cancer.
    Qazi R; Chuang JL; Drobyski W
    Arch Intern Med; 1984 Dec; 144(12):2365-7. PubMed ID: 6508445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of metastases in human breast carcinoma in relation to estrogen receptor status.
    Kamby C; Rose C; Iversen H; Holm NV; Andersen KW; Thorpe SM
    Anticancer Res; 1986; 6(1):107-11. PubMed ID: 3954322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
    Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
    Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet-induced obesity and mammary tumor development in relation to estrogen receptor status.
    Ray A; Nkhata KJ; Grande JP; Cleary MP
    Cancer Lett; 2007 Aug; 253(2):291-300. PubMed ID: 17399892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers.
    McTiernan A; Thomas DB; Johnson LK; Roseman D
    J Natl Cancer Inst; 1986 Oct; 77(4):849-54. PubMed ID: 3463818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary fat consumption and survival among women with breast cancer.
    Gregorio DI; Emrich LJ; Graham S; Marshall JR; Nemoto T
    J Natl Cancer Inst; 1985 Jul; 75(1):37-41. PubMed ID: 3859694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
    Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
    Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy.
    Bartlett JM; Ellis IO; Dowsett M; Mallon EA; Cameron DA; Johnston S; Hall E; A'Hern R; Peckitt C; Bliss JM; Johnson L; Barrett-Lee P; Ellis P
    J Clin Oncol; 2007 Oct; 25(28):4423-30. PubMed ID: 17906205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.